Each filer's latest filing for P8696W104 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
1Globe Capital LLC
13D/A
|
32.3% |
9/12/2025
Event 9/10/2025
|
|
| 1Globe Capital LLC | 32.3% | ||
| 1Globe Biomedical (Hong Kong) Company Limited | 32.3% | ||
| Jiaqiang Li | 32.3% | ||
|
SAIF Partners IV L.P.
13D/A
|
15.0% |
12/17/2025
Event 12/15/2025
|
|
| SAIF Partners IV L.P. | 15.0% | ||
| Saif IV GP, L.P. | 15.0% | ||
| SAIF IV GP Capital Ltd. | 15.0% | ||
| Weidong Yin 13D/A | 8.9% |
7/15/2025
Event 7/10/2025
|
|
|
Advantech Capital L.P.
13D/A
|
8.1% |
7/14/2025
Event 7/8/2025
|
|
| Advantech Capital L.P. | 8.1% | ||
| Advantech Capital Partners Ltd. | 8.1% | ||
| Green Vision Partners Limited | 8.1% | ||
| Prime Success, L.P. | 8.1% | ||
|
Vivo Capital VIII, LLC
13D/A
|
6.3% |
7/11/2025
Event 7/11/2025
|
|
| Vivo Capital VIII, LLC | 1.9% | ||
| Vivo Capital IX, LLC | 6.3% | ||
|
Vivo Capital IX, LLC
13D/A
|
6.3% |
3/19/2025
Event 3/17/2025
|
|
| Vivo Capital VIII, LLC | 1.9% | ||
| Vivo Capital IX, LLC | 6.3% |
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 316 k | $2.04M |
| 2026 Q2 | 28 | 10.5 M | $225M |
| 2026 Q1 | 28 | 10.5 M | $225M |
| 2025 Q4 | 28 | 10.5 M | $225M |
| 2025 Q3 | 27 | 10.5 M | $225M |
| 2025 Q2 | 29 | 10.5 M | $373M |
| 2025 Q1 | 3 | 3.03 M | $334M |
| 2024 Q4 | 4 | 3.05 M | $336M |
| 2024 Q3 | 9 | 14.9 M | $418M |
| 2024 Q2 | 27 | 16.4 M | $420M |
| 2024 Q1 | 27 | 16.5 M | $421M |
| 2023 Q4 | 8 | 3.12 M | $345M |
| 2023 Q3 | 31 | 11.9 M | $386M |
| 2023 Q2 | 31 | 11.8 M | $961M |
| 2023 Q1 | 5 | 8.95 M | $957M |
| 2022 Q4 | 10 | 9.02 M | $380M |
| 2022 Q3 | 32 | 11.8 M | $384M |
| 2022 Q2 | 32 | 11.8 M | $394M |
| 2022 Q1 | 11 | 6.39 M | $41.6M |
| 2021 Q4 | 30 | 12.0 M | $118M |
| 2021 Q3 | 30 | 12.0 M | $123M |
| 2021 Q2 | 29 | 22.8 M | $527M |
| 2021 Q1 | 30 | 22.8 M | $522M |
| 2020 Q4 | 28 | 22.7 M | $186M |
| 2020 Q3 | 26 | 11.9 M | $71.4M |
| 2020 Q2 | 22 | 11.9 M | $69.6M |
| 2020 Q1 | 25 | 11.9 M | $61.7M |
| 2019 Q4 | 26 | 6.07 M | $23.9M |
| 2019 Q3 | 24 | 6.04 M | $36.7M |
| 2019 Q2 | 25 | 11.9 M | $74.9M |
| 2019 Q1 | 26 | 11.9 M | $76.8M |
| 2018 Q4 | 28 | 12.1 M | $83.7M |
| 2018 Q3 | 30 | 12.3 M | $93.4M |
| 2018 Q2 | 30 | 6.56 M | $48.9M |
| 2018 Q1 | 30 | 6.83 M | $58.8M |
| 2017 Q4 | 32 | 7.20 M | $56.7M |
| 2017 Q3 | 35 | 18.1 M | $128M |
| 2017 Q2 | 38 | 17.5 M | $118M |
| 2017 Q1 | 35 | 18.9 M | $108M |
| 2016 Q4 | 38 | 21.7 M | $128M |
| 2016 Q3 | 36 | 11.3 M | $66.9M |
| 2016 Q2 | 37 | 11.9 M | $70.8M |
| 2016 Q1 | 34 | 12.1 M | $77.3M |
| 2015 Q4 | 40 | 12.7 M | $72.5M |
| 2015 Q3 | 37 | 13.2 M | $67.3M |
| 2015 Q2 | 37 | 12.7 M | $66.5M |
| 2015 Q1 | 40 | 12.6 M | $62.6M |
| 2014 Q4 | 43 | 12.9 M | $67.3M |
| 2014 Q3 | 45 | 13.0 M | $62.3M |
| 2014 Q2 | 50 | 13.2 M | $74.3M |
| 2014 Q1 | 52 | 14.5 M | $104M |